These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15077999

  • 1. Addition of fusidic acid impregnated bone cement to systemic teicoplanin therapy in the treatment of rat osteomyelitis.
    Ersoz G, Oztuna V, Coskun B, Eskandari MM, Bayarslan C, Kaya A.
    J Chemother; 2004 Feb; 16(1):51-5. PubMed ID: 15077999
    [Abstract] [Full Text] [Related]

  • 2. Extracorporeal shockwave increases the effectiveness of systemic antibiotic treatment in implant-related chronic osteomyelitis: experimental study in a rat model.
    Inanmaz ME, Uslu M, Isik C, Kaya E, Tas T, Bayram R.
    J Orthop Res; 2014 Jun; 32(6):752-6. PubMed ID: 24676969
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy of tigecycline and teicoplanin in an experimental methicillin-resistant Staphylococcus aureus osteomyelitis model.
    Kandemir O, Oztuna V, Colak M, Akdag A, Camdeviren H.
    J Chemother; 2008 Feb; 20(1):53-7. PubMed ID: 18343744
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
    Yasim A, Gul M, Atahan E, Ciragil P, Aral M, Ergun Y.
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
    [Abstract] [Full Text] [Related]

  • 5. In vivo evaluation of teicoplanin- and calcium sulfate-loaded PMMA bone cement in preventing implant-related osteomyelitis in rats.
    Tuzuner T, Sencan I, Ozdemir D, Alper M, Duman S, Yavuz T, Yildirim M.
    J Chemother; 2006 Dec; 18(6):628-33. PubMed ID: 17267341
    [Abstract] [Full Text] [Related]

  • 6. In vitro release of fusidic acid and teicoplanin from cancellous bone allografts.
    Kanellakopoulou K, Sahinides T, Tsaganos T, Galanakis N, Giamarellou H, Giamarellos-Bourboulis EJ.
    J Chemother; 2008 Oct; 20(5):645-7. PubMed ID: 19028629
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats.
    Ozturan KE, Yucel I, Kocoglu E, Cakici H, Guven M.
    J Orthop Res; 2010 Oct; 28(10):1368-72. PubMed ID: 20839321
    [Abstract] [Full Text] [Related]

  • 8. Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci.
    Roussel-Delvallez M, Wallet F, Barbiery P, Courcol RJ.
    J Chemother; 1997 Feb; 9(1):5-8. PubMed ID: 9106011
    [Abstract] [Full Text] [Related]

  • 9. Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model.
    Zhang X, Jia W, Gu Y, Xiao W, Liu X, Wang D, Zhang C, Huang W, Rahaman MN, Day DE, Zhou N.
    Biomaterials; 2010 Aug; 31(22):5865-74. PubMed ID: 20434766
    [Abstract] [Full Text] [Related]

  • 10. Treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis with vancomycin-loaded VK100 silicone cement: An experimental study in rats.
    Neyisci C, Erdem Y, Bilekli AB, Demiralp B, Kose O, Bek D, Korkusuz F, Kankilic B.
    J Orthop Surg (Hong Kong); 2018 Aug; 26(1):2309499017754093. PubMed ID: 29382296
    [Abstract] [Full Text] [Related]

  • 11. A bioresorbable calcium phosphate delivery system with teicoplanin for treating MRSA osteomyelitis.
    Lazarettos J, Efstathopoulos N, Papagelopoulos PJ, Savvidou OD, Kanellakopoulou K, Giamarellou H, Giamarellos-Bourboulis EJ, Nikolaou V, Kapranou A, Papalois A, Papachristou G.
    Clin Orthop Relat Res; 2004 Jun; (423):253-8. PubMed ID: 15232458
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo efficacies of teicoplanin-loaded calcium sulfate for treatment of chronic methicillin-resistant Staphylococcus aureus osteomyelitis.
    Jia WT, Luo SH, Zhang CQ, Wang JQ.
    Antimicrob Agents Chemother; 2010 Jan; 54(1):170-6. PubMed ID: 19917757
    [Abstract] [Full Text] [Related]

  • 13. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E, Gul M, Ergun Y, Eroglu E.
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Orhan Z, Cevher E, Yildiz A, Ahiskali R, Sensoy D, Mülazimoğlu L.
    Arch Orthop Trauma Surg; 2010 Jan; 130(1):135-42. PubMed ID: 19434413
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model.
    Jia WT, Fu Q, Huang WH, Zhang CQ, Rahaman MN.
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7571-80. PubMed ID: 26416858
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Three-times weekly teicoplanin as outpatient treatment of chronic osteoarticular infections.
    Tascini C, Tagliaferri E, Di Paolo A, Ciofi L, Del Tacca M, Lambelet P, Menichetti F.
    J Chemother; 2009 Aug; 21(4):421-5. PubMed ID: 19622461
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.